Edge Foods rebrands as Edge Biotech with a renewed focus on developing bioactive ingredients for cosmetic product formulations



Stem-cell derived bioactive ingredients continue to become an increasingly popular option for topical product formulations, as evidenced by B2C brands like FactorFive, Act+Acre, Juice Beauty, and Indie Lee. In the B2B space, there is still significant R&D being performed into ethical production of effective stem cell bioactives – and Edge Foods, recently rebranded to Edge Biotech, is one company making strides in this area.

To learn more about recent advancements in stem-cell derived cosmetic ingredient R&D, including the company’s innovations in ‘fibroblast and mesenchymal stem cell conditioned media,’ and for further insights into the growing demand for these types of topical ingredients for beauty product formulations, CosmeticsDesign interviewed Manny Tamargo, CEO and Co-Founder of Edge Biotech.

CDU: Can you share some brief background about your experience, your company, and your relationship with the cosmetics and personal care product industries?​ 

Manny Tamargo (MT):​ I’ve been a vegetarian for 10 years and I love that I can use my scientific expertise to work on a solution that I care about — removing animals from the supply chain.

I have extensive experience in stem cell-derived cardiac muscle tissue engineering and bioreactor fabrication. I used stem cell engineering technologies to create human heart muscle in the lab.

Borrowing from these themes, at Edge, we have captured and packaged the power of stem cell communication for a cause we are passionate about. I am an author of nine publications and five provisional patents, including two from my PhD and three with Edge. 

We realize that regenerative medicine has the power to reshape human health and animal welfare. Therefore, our mission is to utilize our expertise to create animal-free animal products that would otherwise require animal sacrifice.



Source link

About The Author